PMID- 25267345 OWN - NLM STAT- MEDLINE DCOM- 20150831 LR - 20181202 IS - 1744-7593 (Electronic) IS - 1742-5247 (Linking) VI - 12 IP - 3 DP - 2015 Mar TI - Advances in oral controlled drug delivery: the role of drug-polymer and interpolymer non-covalent interactions. PG - 441-53 LID - 10.1517/17425247.2015.966685 [doi] AB - INTRODUCTION: After more than four decades of intense research, oral controlled drug delivery systems (DDSs) still represent a topic of major interest for pharmaceutical scientist and formulators. This can be explained in part by considering the economic value of oral DDSs whose market accounts for more than half of the overall drug delivery market. Polymeric systems based on drug-polymer non-covalent interaction represent a limited, but growing part of the field. Despite the large amount of literature and published reviews covering specific aspects, there is still need for a review of the relevant literature providing a general picture of the topic. AREAS COVERED: The present review aims at presenting the latest findings in drug-polymer and interpolymer non-covalent interactions in oral controlled delivery while providing a specific perspective and a critical point of view, particularly on the tools and methods used for the study of these DDSs. Four main sections are considered: i) ionic interactions between drugs and polymers; ii) interpolymer complexes; iii) hydrogen bond; and iv) hydrophobic interactions. EXPERT OPINION: The largest part of the scientific literature deals with systems based on drug-polymer ionic interactions while hydrogen bonding and hydrophobic interaction though, very promising, are more difficult to exploit, and therefore less studied. An accurate and exhaustive representation of the specific role of the chemical functions in establishing predictable interactions between drug and polymers is still required. FAU - De Robertis, Simona AU - De Robertis S AD - PhD Student, University of Parma, Department of Pharmacy , Parma , Italy. FAU - Bonferoni, Maria Cristina AU - Bonferoni MC FAU - Elviri, Lisa AU - Elviri L FAU - Sandri, Giuseppina AU - Sandri G FAU - Caramella, Carla AU - Caramella C FAU - Bettini, Ruggero AU - Bettini R LA - eng PT - Journal Article PT - Review DEP - 20140930 PL - England TA - Expert Opin Drug Deliv JT - Expert opinion on drug delivery JID - 101228421 RN - 0 (Delayed-Action Preparations) RN - 0 (Excipients) RN - 0 (Ions) RN - 0 (Polymers) SB - IM MH - Administration, Oral MH - Chemistry, Pharmaceutical/*methods MH - Delayed-Action Preparations/*chemistry MH - Drug Delivery Systems/*methods MH - Drug Liberation MH - Excipients/*chemistry MH - Hydrogen Bonding MH - Ions/chemistry MH - Polymers/*chemistry OTO - NOTNLM OT - Eudragit OT - alginate OT - carrageenan OT - chitosan OT - controlled release OT - drug-polymer interaction OT - interpolymer complex OT - oral delivery OT - polyelectrolyte complex EDAT- 2014/10/01 06:00 MHDA- 2015/09/01 06:00 CRDT- 2014/10/01 06:00 PHST- 2014/10/01 06:00 [entrez] PHST- 2014/10/01 06:00 [pubmed] PHST- 2015/09/01 06:00 [medline] AID - 10.1517/17425247.2015.966685 [doi] PST - ppublish SO - Expert Opin Drug Deliv. 2015 Mar;12(3):441-53. doi: 10.1517/17425247.2015.966685. Epub 2014 Sep 30.